Veralox Therapeutics Inc. Announces Jonathan Mow as Chief Executive Officer
Veralox Therapeutics has announced the appointment of Jonathan Mow as the company’s new Chief Executive Officer. Jonathan Mow brings over 25 years of experience in biotechnology management. He most recently served as the CEO of PhaseBio Pharmaceuticals.
Veralox Therapeutics is a biotechnology company focused on the development of innovative therapies.